Chile Could Greenlight AstraZeneca Vaccine “Within Days of US/UK Approval”

Chile is already among the best-placed in the region for vaccine deals, with an agreement for 10 million doses from Pfizer BioNtech, 60 million doses over three years from China’s Sinovac and 7.6 million vaccine doses through the global vaccine distribution scheme COVAX.

RIO DE JANEIRO, BRAZIL - The UK-based pharmaceutical company AstraZeneca has been conducting late-stage trials of its vaccine, developed with Oxford University, in Chile as well as in Brazil, the UK, the United States and South Africa.

Chile has signed a deal to buy 14.4 million doses of the drug, an amount that would vaccinate half that number of people, or nearly 40% of the country’s population.

Chile is already among the best-placed in the region for vaccine deals, with an agreement for 10 million doses from Pfizer BioNtech, 60 million doses over three years from . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?